A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis

PHASE2TerminatedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

November 21, 2024

Study Completion Date

November 21, 2024

Conditions
Multiple Sclerosis
Interventions
DRUG

SAR443820

Tablet by oral administration

OTHER

Placebo

Tablet by oral administration

Trial Locations (35)

1407

Investigational Site Number : 1000001, Sofia

1431

Investigational Site Number : 1000002, Sofia

1680

Investigational Site Number : 1000003, Sofia

3900

Investigational Site Number : 0560003, Overpelt

9000

Investigational Site Number : 0560002, Ghent

14033

Investigational Site Number : 2500004, Caen

20132

Investigational Site Number : 3800002, Milan

20133

Investigational Site Number : 3800003, Milan

28007

Investigational Site Number : 7240004, Madrid / Madrid

28034

Investigational Site Number : 7240006, Madrid

28040

Investigational Site Number : 7240003, Madrid

30120

Investigational Site Number : 7240005, Murcia

41009

Investigational Site Number : 7240002, Seville

67098

Investigational Site Number : 2500003, Strasbourg

75013

Investigational Site Number : 2500001, Paris

86077

Investigational Site Number : 3800001, Pozzilli

97074

Investigational Site Number : 2760002, Würzburg

200040

Investigational Site Number : 1560002, Shanghai

300052

Investigational Site Number : 1560001, Tianjin

610041

Investigational Site Number : 1560003, Chengdu

710038

Investigational Site Number : 1560004, Xi'an

8380456

Investigational Site Number : 1520001, Santiago

BE-1200

Investigational Site Number : 0560001, Brussels

K1H 8L6

Investigational Site Number : 1240002, Ottawa

M5B 1W8

Investigational Site Number : 1240004, Toronto

J8Y 1W2

Investigational Site Number : 1240001, Gatineau

G6W0M5

Investigational Site Number : 1240003, Lévis

06001

Investigational Site Number : 2500002, Nice

09126

Investigational Site Number : 3800005, Cagliari

62-064

Investigational Site Number : 6160004, Plewiska

40-571

Investigational Site Number : 6160002, Katowice

40-686

Investigational Site Number : 6160005, Katowice

31-503

Investigational Site Number : 6160001, Krakow

41-800

Investigational Site Number : 6160006, Zabrze

08035

Investigational Site Number : 7240001, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05630547 - A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis | Biotech Hunter | Biotech Hunter